FDA Inspection 1109017 — New York Presbyterian Hospital Weill Cornell Medical College

New York Presbyterian Hospital Weill Cornell Medical College — FEI 3003972369

The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on September 25, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)